|
Effects of Cosmetic Therapy on Cosmetic Side Effects of Chemotherapy to Improve the Quality of Life of Cancer Patients
|
Abstract:
Introduction: Chemotherapy-induced skin symptoms are diverse and vary in severity. As more cancer patients live in the community while continuing treatment, changes in appearance due to skin disorders reduce their quality of life (QOL). Cosmetic therapy may be one effective method to improve QOL. We investigated the effects of cosmetic therapy on QOL of cancer patients with chemotherapy-induced changes in appearance. Methods: Female patients aged ≥ 20 years who underwent outpatient chemotherapy at our hospital and developed CTCAE ≥ grade 2 eyebrow or eyelash alopecia, or ≥ grade 1 skin hyperpigmentation were enrolled in this prospective study. Cosmetic therapy was performed by nurses who acquired skills in cosmetic therapy. QOL indices before and after cosmetic therapy were assessed and compared using Skindex-16, Visual Analogue Scale (VAS) skin condition and makeup satisfaction, and Cancer Patient Self-Efficacy Scale. Results: The study included 21 patients, 16 of whom were evaluated after cosmetic therapy. The mean age was 63.5 (43 - 79) years. The Number of cases by CTCAE grade were eyebrow alopecia grades 0/1/2 = 5/6/5, eyelash alopecia grades 0/1/2 = 3/7/6, and pigmentation grades 0/1/2 = 1/13/2. The Skindex-16 emotional score improved from 31.0 before to 3.7 after cosmetic therapy (p < 0.01), and overall score combining symptom, emotional, and functional subscales improved from 18.3 to 2.7 (p < 0.01). VAS skin condition satisfaction improved from 35.6 to 58.9 (p < 0.01) and makeup satisfaction improved from 44.5 to 80 (p < 0.01). Conclusions: Implementation of cosmetic therapy for cancer patients improved negative emotions caused by appearance changes associated with chemotherapy-induced skin damage, suggesting that cosmetic therapy improves QOL.
[1] | Nozawa, K., Shimizu, C., Kakimoto, M., Mizota, Y., Yamamoto, S., Takahashi, Y., et al. (2013) Quantitative Assessment of Appearance Changes and Related Distress in Cancer Patients. Psycho-Oncology, 22, 2140-2147. https://doi.org/10.1002/pon.3268 |
[2] | Hackbarth, M., Haas, N., Fotopoulou, C., Lichtenegger, W. and Sehouli, J. (2008) Chemotherapy-Induced Dermatological Toxicity: Frequencies and Impact on Quality of Life in Women’s Cancers. Results of a Prospective Study. Supportive Care in Cancer, 16, 267-273. https://doi.org/10.1007/s00520-007-0318-8 |
[3] | Yorulmaz, A., Dogan, M., Artuz, F. and Zengin, N. (2017) Comparison of Pigmentary Side Effects of Taxanes and Anthracyclines: An Onychoscopic Evaluation. Cutaneous and Ocular Toxicology, 36, 135-139. https://doi.org/10.3109/15569527.2016.1173698 |
[4] | Lacouture, M. and Sibaud, V. (2018) Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails. American Journal of Clinical Dermatology, 19, 31-39. https://doi.org/10.1007/s40257-018-0384-3 |
[5] | Choi, E.K., Kim, I., Chang, O., Kang, D., Nam, S., Lee, J.E., et al. (2014) Impact of Chemotherapy-Induced Alopecia Distress on Body Image, Psychosocial Well-Being, and Depression in Breast Cancer Patients. Psycho-Oncology, 23, 1103-1110. https://doi.org/10.1002/pon.3531 |
[6] | Choi, Y., Lee, J.H., Kim, Y.H., Lee, Y.S., Chang, H., Park, C.S., et al. (2014) Impact of Postthyroidectomy Scar on the Quality of Life of Thyroid Cancer Patients. Annals of Dermatology, 26, 693-699. https://doi.org/10.5021/ad.2014.26.6.693 |
[7] | Holme, S.A., Beattie, P.E. and Fleming, C.J. (2002) Cosmetic Camouflage Advice Improves Quality of Life. British Journal of Dermatology, 147, 946-949. https://doi.org/10.1046/j.1365-2133.2002.04900.x |
[8] | Tanioka, M., Yamamoto, Y., Kato, M. and Miyachi, Y. (2010) Camouflage for Patients with Vitiligo Vulgaris Improved Their Quality of Life. Journal of Cosmetic Dermatology, 9, 72-75. https://doi.org/10.1111/j.1473-2165.2010.00479.x |
[9] | Matsuoka, Y., Yoneda, K., Sadahira, C., Katsuura, J., Moriue, T. and Kubota, Y. (2006) Effects of Skin Care and Makeup under Instructions from Dermatologists on the Quality of Life of Female Patients with Acne Vulgaris. The Journal of Dermatology, 33, 745-752. https://doi.org/10.1111/j.1346-8138.2006.00174.x |
[10] | Hayashi, N., Imori, M., Yanagisawa, M., Seto, Y., Nagata, O. and Kawashima, M. (2005) Make-Up Improves the Quality of Life of Acne Patients without Aggravating Acne Eruptions during Treatments. European Journal of Dermatology, 15, 284-287. |
[11] | Haley, A.C., Calahan, C., Gandhi, M., West, D.P., Rademaker, A. and Lacouture, M.E. (2011) Skin Care Management in Cancer Patients: An Evaluation of Quality of Life and Tolerability. Supportive Care in Cancer, 19, 545-554. https://doi.org/10.1007/s00520-010-0851-8 |
[12] | Amiel, P., Dauchy, S., Bodin, J., Cerf, C., Zenasni, F., Pezant, E., et al. (2009) Evaluating Beauty Care Provided by the Hospital to Women Suffering from Breast Cancer: Qualitative Aspects. Supportive Care in Cancer, 17, 839-845. https://doi.org/10.1007/s00520-009-0620-8 |
[13] | Titeca, G., Poot, F., Cassart, D., Defays, B., Pirard, D., Comas, M., et al. (2007) Impact of Cosmetic Care on Quality of Life in Breast Cancer Patients during Chemotherapy and Radiotherapy: An Initial Randomized Controlled Study. Journal of the European Academy of Dermatology and Venereology, 21, 771-776. https://doi.org/10.1111/j.1468-3083.2006.02080.x |
[14] | Wakeda, T., Okamura, T., Kawahara, T. and Heike, Y. (2020) Camouflage Makeup Improves Quality of Life in Cancer Patients with Treatment-Related Skin Changes. Tumori Journal, 106, 95-100. https://doi.org/10.1177/0300891619867844 |
[15] | Sibaud, V., Lebœuf, N.R., Roche, H., Belum, V.R., Gladieff, L., Deslandres, M., et al. (2016) Dermatological Adverse Events with Taxane Chemotherapy. European Journal of Dermatology, 26, 427-443. https://doi.org/10.1684/ejd.2016.2833 |
[16] | Deutsch, A., Leboeuf, N.R., Lacouture, M.E. and McLellan, B.N. (2020) Dermatologic Adverse Events of Systemic Anticancer Therapies: Cytotoxic Chemotherapy, Targeted Therapy, and Immunotherapy. American Society of Clinical Oncology Educational Book, 40, 485-500. https://doi.org/10.1200/edbk_289911 |
[17] | Rayner, V.L. (1995) Camouflage Therapy. Dermatologic Clinics, 13, 467-472. https://doi.org/10.1016/s0733-8635(18)30093-7 |
[18] | Higaki, Y., Kawamoto, K., Kamo, T., Horikawa, N., Kawashima, M. and Chren, M. (2002) The Japanese Version of Skindex‐16: A Brief Quality‐of‐Life Measure for Patients with Skin Diseases. The Journal of Dermatology, 29, 693-698. https://doi.org/10.1111/j.1346-8138.2002.tb00205.x |
[19] | Chren, M., Lasek, R.J., Sahay, A.P. and Sands, L.P. (2001) Measurement Properties of Skindex-16: A Brief Quality-of-Life Measure for Patients with Skin Diseases. Journal of Cutaneous Medicine and Surgery, 5, 105-110. https://doi.org/10.1177/120347540100500202 |
[20] | Fayers, P.M. and Machin, D. (2007) Quality of Life. Wiley, John Wiley & Sons, Ltd. https://doi.org/10.1002/9780470024522 |
[21] | Tsukamoto, N. (1998) Construction of a Self-Efficacy Scale for Cancer Patients. Japanese Journal of Nursing Research (Kango Kenkyu), 31, 198-206. |
[22] | Tuckman, A. (2017) The Potential Psychological Impact of Skin Conditions. Dermatology and Therapy, 7, 53-57. https://doi.org/10.1007/s13555-016-0169-7 |
[23] | Colleoni, M., Mandala, M., Peruzzotti, G., Robertson, C., Bredart, A. and Goldhirsch, A. (2000) Depression and Degree of Acceptance of Adjuvant Cytotoxic Drugs. The Lancet, 356, 1326-1327. https://doi.org/10.1016/s0140-6736(00)02821-x |
[24] | Fluhr, J.W., Miteva, M., Primavera, G., Ziemer, M., Elsner, P. and Berardesca, E. (2007) Functional Assessment of a Skin Care System in Patients on Chemotherapy. Skin Pharmacology and Physiology, 20, 253-259. https://doi.org/10.1159/000104423 |